Celularity Inc (CELU) Live Share Price, Invest From India

Celularity Inc Stock Performance

as on May 8, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.90
Day's Price Range
$0.94
$0.91
1.10%
Downside
3.30%
Upside
52 Week's Low
52 Week's High
$0.88
52-Week Price Range
$4.35
$0.91
3.30%
Downside
378.02%
Upside

Celularity Inc share price movements today

Previous Close: $0.93
Open: $0.92
Volume: 583.5K
Day's Low - High: $0.90 - $0.94
52 Week Low - High: $0.88 - $4.35

Celularity Inc Historical Returns

1 Month Return: -33.76 %
3 Month Return: -30.19 %
1 Year Return: -45.33 %
3 Year Return: -80.24 %
5 Year Return: 0 %

Celularity Inc Stock Fundamentals & Key Indicators

Check Celularity Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.9M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.61%

PE Ratio (TTM)

PEG Ratio

EBITDA

-54.0M

Revenue (TTM)

26.6M

Profit Margin

0.00%

Return On Equity TTM

-6367.24%

Celularity Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Celularity Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Celularity Inc	BUY	$26.9M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	125.37%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	97.67%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	42.75%	17.6	29.65%

Stock Returns calculator for Celularity Inc Stock including INR - Dollar returns

The Celularity Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Celularity Inc investment value today

Current value as on today

₹60,978

Returns

-₹39,022

(-39.02%)

Returns from Celularity Inc Stock

-₹45,181 (-45.18%)

Dollar Impact

₹6,159 (+6.16%)

Analyst Recommendation on Celularity Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Celularity Inc. Average target price of $2.5

Celularity Inc Share Price Target

Get share price movements and forecasts by analysts on Celularity Inc.

What analysts predicted

63.6%UPSIDE

Target Price

$2.5

Current Price

$0.91

Analyzed by

7 Analysts

Target

$2.50

Celularity Inc target price $2.5, a slight upside of 63.6% compared to current price of $0.91. According to 7 analysts rating.

Indian Investors' Interest in Celularity Inc Stock

Search interest for Celularity Inc Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 8, 2026 to May 8, 2026

Change:27% versus previous 30 day period

Celularity Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	3	14	12	9	18	18	5	5	4	4
Gross Profit	0	13	2	5	10	10	0	3	-3	8
Operating Income	-99	-7	13	-11	-9	-9	-15	-12	-22	-22
EBITDA	-90	-	-8	-12	-	-7	-20	-19	-	-21
Interest Expense	0	1	0	1	1	1	1	1	0	0
Depreciation	2	2	1	1	1	1	1	1	1	-
Income Before Tax	-93	-22	9	-16	-13	-13	-24	-23	-24	-24
Income Tax Expense	2	-	0	-13	-	13	-	0	-	0
Net Income	-93	-22	9	-16	-13	-13	-24	-23	-24	-24
Net Profit Margin	-2479.56%	-149.94%	78.82%	-173.17%	-73.31%	-73.31%	-427.55%	-436.66%	-593.62%	-593.62%

Celularity Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	17	21	14	21	17	22	54	26
Gross Profit	10	14	9	11	-1	6	39	20
Operating Income	0	-264	-151	-109	-25	-76	-38	-61
EBITDA	0	-70	-202	-88	-138	-	-43	-77
Interest Expense	-	3	2	3	3	3	6	6
Depreciation	-	-	8	8	9	9	7	7
Income Before Tax	0	-267	-212	-100	14	-196	-57	-91
Income Tax Expense	21	-56	-4	0	0	-	0	0
Net Income	0	-211	-208	-100	14	-196	-57	-91
Net Profit Margin	-0.01%	-1001.94%	-1458.42%	-469.27%	78.95%	-862.04%	-106.77%	-345.76%

Celularity Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-22	9	-16	-13	-13	-24	-23	-24	-24
Operating Cash Flow	-4	-4	0	1	1	0	-4	-5	-5
Investing Cash Flow	-	0	0	-	-1	-	2	-	-
Financing Cash Flow	6	0	0	0	0	1	3	11	11
Change in Cash	1	-4	0	0	0	0	0	6	6

Celularity Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	5	-208	-100	14	-196	-57	-91
Operating Cash Flow	-1	-63	-110	-137	-38	-6	-13
Investing Cash Flow	-286	-12	-5	-5	-	0	-
Financing Cash Flow	288	102	98	119	24	6	18
Change in Cash	0	26	-17	-23	-18	0	5

Global Institutional Holdings in Celularity Inc

Funds	Holdings
Royal Bank of Canada	0.06%
Tower Research Capital LLC	0.02%
Vanguard Group Inc	2.35%
Citadel Advisors Llc	0.27%
SIMPLEX TRADING, LLC	0.03%

See all

Insights on Celularity Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.4% return, outperforming this stock by 103.2%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 32.8% return, outperforming this stock by 76.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -23.07M → -24.36M (in $), with an average decrease of 2.8% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 5 quarters, 18.13M → 4.10M (in $), with an average decrease of 24.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, CELU stock has moved down by -32.1%

About Celularity Inc

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Organisation	Celularity Inc
Headquarters	170 Park Avenue, Florham Park, NJ, United States, 07932
Industry	Biotechnology
CEO	Dr. Robert Joseph Hariri M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Celularity Inc

Name	Title
Mr. Carlos Ramirez	SVP of Investor Relations
Sharmila Koppisetti M.D.	Senior Vice President of Clinical Dev. Immunology & Drug Safety
Mr. Tim Wilk	Senior Vice President of Technical Operations
Mr. David Jakob Lemus CPA, M.S., MBA	Treasurer
Dr. Robert Joseph Hariri M.D., Ph.D.	Founder, CEO & Chairman
Mr. John R. Haines	Senior EVP, Corporate Secretary, Global Manager & Chief Administrative Officer
John Sprague	Acting Chief Financial Officer

FAQs

What is Celularity Inc share price today?

Celularity Inc share price today is $0.91 as on May 8, 2026 at 8:46 am IST at the close of the market. Celularity Inc share today touched a day high of $0.94 and a low of $0.9.

What is the 52 week high and 52 week low for Celularity Inc share?

Celularity Inc share touched a 52 week high of $4.35 on July 22, 2025 and a 52 week low of $0.88 on May 4, 2026. Celularity Inc stock price today i.e. May 8, 2026 at 8:46 am IST is closed at $0.91,which is 79.08% down from its 52 week high and 3.41% up from its 52 week low.

What is Celularity Inc's market capitalisation today?

Celularity Inc market capitalisation is $0.00T as on May 8, 2026 at 8:46 am IST.

How to invest in Celularity Inc Stock (CELU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Celularity Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celularity Inc Shares that will get you 1.6484 shares as per Celularity Inc share price of $0.91 per share as on May 8, 2026 at 8:46 am IST.

What is the minimum amount required to buy Celularity Inc Stock (CELU) from India?

Indian investors can start investing in Celularity Inc (CELU) shares with as little as ₹94.24 or $1 (as of May 8, 2026 at 1:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Celularity Inc stock (as per the Rupee-Dollar exchange rate as on May 8, 2026 at 1:39 pm IST). Based on Celularity Inc share’s latest price of $0.91 as on May 8, 2026 at 8:46 am IST, you will get 10.9890 shares of Celularity Inc. Learn more about fractional shares .